Analyst Price Targets — AVTE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 17, 2024 4:07 pm | Liisa Bayko | Evercore ISI | $2.00 | $1.65 | TheFly | Aerovate Therapeutics downgraded to In Line from Outperform at Evercore ISI |
| June 17, 2024 12:15 pm | Eun Yang | Jefferies | $2.00 | $1.65 | StreetInsider | Jefferies Downgrades Aerovate Therapeutics Inc (AVTE) to Hold |
| April 1, 2024 5:54 am | Tiago Fauth | Wells Fargo | $35.00 | $29.57 | StreetInsider | Wells Fargo Adds Aerovate Therapeutics Inc (AVTE) to Q2 '24 Tactical Ideas List |
| March 25, 2024 7:56 am | Eun Yang | Jefferies | $65.00 | $26.95 | StreetInsider | Aerovate Therapeutics Inc (AVTE) PT Raised to $65 at Jefferies, 'valuation does not suggest data needs to be better than sotatercept' |
No recent news available for AVTE.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AVTE.
U.S. House Trading
No House trades found for AVTE.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.